Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer

Folia Biol (Praha). 1999;45(4):115-9.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cancer Vaccines / therapeutic use*
  • Genetic Therapy*
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
  • Hematopoiesis / drug effects
  • Humans
  • Immunotherapy, Active*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Nude
  • Neoplasms / therapy*
  • Neoplasms, Experimental / therapy
  • Rats
  • Sarcoma, Experimental / therapy
  • Tumor Cells, Cultured / transplantation
  • Vaccines, DNA / therapeutic use*

Substances

  • Cancer Vaccines
  • Vaccines, DNA
  • Granulocyte-Macrophage Colony-Stimulating Factor